SOPs for BA-BE Studies V 2.0

To define a standardized procedure for ensuring full compliance with the provisions of Schedule Y of the Drugs and Cosmetics Rules, 1945, during the planning and conduct of Bioavailability/Bioequivalence (BA/BE) studies in India.
Click to read the full article.

To define the procedure for identifying, documenting, investigating, and mitigating cold chain breaches during the storage of clinical samples in Bioavailability/Bioequivalence (BA/BE) studies.
Click to read the full article.

To define a standardized procedure for the transfer of clinical samples (e.g., blood, plasma) from satellite clinic sites to the central laboratory in a secure and temperature-controlled manner to ensure sample integrity and traceability in BA/BE studies.
Click to read the full article.

To establish a robust and standardized procedure for the prevention of cross-contamination of clinical samples during collection, processing, labeling, storage, and transport in Bioavailability/Bioequivalence (BA/BE) studies.
Click to read the full article.

To establish a uniform process for identifying, documenting, evaluating, and resolving protocol violations that occur during the conduct of Bioavailability/Bioequivalence (BA/BE) studies, including implementation of Corrective and Preventive Actions (CAPA).
Click to read the full article.

To define a standardized procedure for the scheduling, execution, and documentation of preventive maintenance for clinical equipment used in the conduct of Bioavailability/Bioequivalence (BA/BE) studies to ensure operational readiness and compliance with regulatory standards.
Click to read the full article.

To define the procedure for systematic environmental monitoring in volunteer housing, dosing, and recreation areas during the conduct of BA/BE studies to ensure hygienic, safe, and comfortable conditions for study subjects.
Click to read the full article.

To define the standardized cleaning and disinfection procedures for dosing rooms used in BA/BE studies to maintain aseptic conditions, minimize cross-contamination, and comply with applicable GCP and hygiene standards.
Click to read the full article.

To establish a standardized and compliant procedure for the secure collection, tracking, handling, and disposal of biological waste generated during BA/BE studies in accordance with biomedical waste management regulations.
Click to read the full article.

To define a systematic and compliant procedure for managing controlled documents during the clinical phase of Bioavailability/Bioequivalence (BA/BE) studies, ensuring integrity, traceability, and accessibility throughout the document lifecycle.
Click to read the full article.